Shanghai, China Elite Capital is the famous VC, which was founded in 1998. The venture was found in Asia in China. The leading representative office of defined VC is situated in the Beijing.
The important activity for fund was in 2018. Considering the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 50 - 100 millions dollars are the general things for fund.
The typical case for the fund is to invest in rounds with 6-7 participants. Despite the Elite Capital, startups are often financed by CrestValue. The meaningful sponsors for the fund in investment in the same round are Yingke Capital, Sangel Capital, SDIC Venture Capital.
The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China. We can highlight the next thriving fund investment areas, such as Pharmaceutical, Health Care. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline KBP Biosciences, Haihe Biopharma, Kuaile Zhihui
| Fund Name | Location |
| ACT Capital Management | - |
| Carbon Black | Massachusetts, United States, Waltham |
| Efficient Capacity fund | California, San Francisco, United States |
| Fenox Venture Capital | Costa Rica, San José, San Jose Province |
| Garu Investments | - |
| Juxin Ziben | China, Hangzhou, Zhejiang |
| Kindler Capital | - |
| Momentum Venture Management | California, Pasadena, United States |
| MUFG Union Bank | New York, New York, United States |
| NextWaveBio | Connecticut, East Hartford, United States |
| Olympus Partners | Connecticut, Stamford, United States |
| Pureos Bioventures | Küsnacht, Switzerland, Zurich |
| Safar Partners | Czech Republic, Prague, Prague |
| Stobart Group | England, Germany, Nordrhein-Westfalen |
| Sustainable Asset Management | Central, Central Region, Singapore |
| Tao Tsuot | HaMerkaz, Israel, Petah Tiqva |
| Ventureworks India | India, Maharashtra, Mumbai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
| $1M | 29 Aug 2016 | Beijing | |||
Kangai Weishi | $3M | 01 Nov 2015 | Beijing | ||
Crabyter | $3M | 08 Sep 2015 | Putuo, Shanghai, China | ||
Pharmplus | $3M | 07 May 2015 | China, Jiangsu |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
| $1M | 29 Aug 2016 | Beijing | |||
Kangai Weishi | $3M | 01 Nov 2015 | Beijing | ||
Crabyter | $3M | 08 Sep 2015 | Putuo, Shanghai, China | ||
Pharmplus | $3M | 07 May 2015 | China, Jiangsu |
